| IL285151B1 (en) | | Methods of treating fgf21-associated disorders |
| ZA201705673B (en) | | Methods for treating skin |
| IL269371A (en) | | Treatment methods |
| IL279308A (en) | | Methods for treating hepcidin-mediated disorders |
| SG10202007559PA (en) | | Skin treatment apparatus |
| GB201608885D0 (en) | | Treatment |
| PL3215219T3 (en) | | Skin treatment system |
| GB201502137D0 (en) | | Treatment |
| PT3160464T (en) | | 6-hydroxybuspirone for use in the treatment of movement disorders |
| GB201607388D0 (en) | | Treatment of impulsivity-related disorders |
| GB201409363D0 (en) | | Skin cancer treatment |
| GB201615444D0 (en) | | Dermatological treatment apparatus |
| SG11201710686PA (en) | | Hair treatment agent |
| ZA202002910B (en) | | Treatment of skin disorders |
| GB201604658D0 (en) | | Treatment for pain |
| EP3200795A4 (en) | | Use of agents for treating fat-related disorders |
| IL255012A0 (en) | | Compositopns and methods for treating skin conditions |
| GB201604359D0 (en) | | Treatment of tissue disorders |
| GB201503008D0 (en) | | Treatment |
| GB201602011D0 (en) | | Treating skin disorders |
| GB201703768D0 (en) | | Skin treatment methods |
| GB201703734D0 (en) | | Skin treatment methods |
| GB201718985D0 (en) | | Treatment |
| GB201713650D0 (en) | | Treatment |
| GB201700308D0 (en) | | Hair treatment methods |